COMPARISON OF TWO TREATMENT REGIMENS, HYBRID THERAPY ANDSEQUENTIAL THERAPY FOR TREATMENT OF HELICOBACTER PYLORI IN PATIENTS WITH PEPTIC ULCER DISEASE
Phase 3
Completed
- Conditions
- Health Condition 1: null- PEPTIC ULCER DISEASE AND GASTRITISHealth Condition 2: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
- Registration Number
- CTRI/2016/04/006881
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 194
Inclusion Criteria
All consecutive patients with peptic ulcer disease and gastritis with H. pylori infection.
Exclusion Criteria
1.Patients who have received any form of H.pylori eradication therapy in the past.
2.Patients with associated findings in endoscopy such as malignancy, portal hypertensive gastropathy etc.
3.Patients with gastric ulcers confirmed to be malignant by endoscopic biopsy will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method